Koç H - Search Results

1

P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.

Beksaç M, Akan H, Koç H, Ilhan O, Ertürk S, Güneyli A, Ikizünal Y, Sardaş OS. Beksaç M, et al. Among authors: koc h. Med Oncol Tumor Pharmacother. 1992;9(2):101-5. Med Oncol Tumor Pharmacother. 1992. PMID: 1364132

2

The clinical correlations of serum tumor necrosis factor-alpha in acute leukemias: a predictor of response and relapse?

Beksaç M, Ertürk S, Akan H, Koç H, Ilhan O. Beksaç M, et al. Among authors: koc h. Leukemia. 1993 Nov;7(11):1773-6. Leukemia. 1993. PMID: 8231245

3

The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia.

Kutlay S, Beksac M, Dalva K, Ilhan O, Koc H, Akan H, Ozcan M. Kutlay S, et al. Among authors: koc h. Leuk Lymphoma. 2003 May;44(5):791-5. doi: 10.1080/1042819031000067512. Leuk Lymphoma. 2003. PMID: 12802915 Clinical Trial.

4

Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey.

Ilhan O, Akan H, Koç H, Gürman G, Arslan O, Ozcan M, Erdi H, Erdem C, Konuk N, Uysal A, Beksaç M. Ilhan O, et al. Among authors: koc h. Hematol Cell Ther. 1997 Jun;39(3):133-6. doi: 10.1007/s00282-997-0133-1. Hematol Cell Ther. 1997. PMID: 9262989

5

Use of high-dose chemotherapy plus granulocyte colony-stimulating factor for the salvage of refractory or resistant-relapse lymphoma patients without stem cell support.

Koç H, Arslan O, Gürman G, Akan H, Ozcan M, Ilhan O, Aydoğdu I, Arat M, Beksaç M, Konuk N, Uysal A. Koç H, et al. Acta Haematol. 1997;98(3):136-9. doi: 10.1159/000203607. Acta Haematol. 1997. PMID: 9352743 Clinical Trial.

6

Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?

Koç H, Gürman G, Arslan O, Ozcan M, Dilek I, Akan H, Ilhan O, Konuk N, Beksaç M, Uysal A. Koç H, et al. J Chemother. 1997 Oct;9(5):371-6. doi: 10.1179/joc.1997.9.5.371. J Chemother. 1997. PMID: 9373793 Clinical Trial.

7

HLA DR2: a predictive marker in response to cyclosporine therapy in aplastic anemia.

Ihan O, Beksaç M, Arslan O, Ozcan M, Koç H, Akan H, Gürman G, Konuk N, Uysal A. Ihan O, et al. Among authors: koc h. Int J Hematol. 1997 Oct;66(3):291-5. doi: 10.1016/s0925-5710(97)00054-6. Int J Hematol. 1997. PMID: 9401274

8

Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.

Dilek I, Demirer T, Ustün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Ozcan M, Ilhan O, Akan H. Dilek I, et al. Among authors: koc h. Bone Marrow Transplant. 1998 Jun;21(11):1159-61. doi: 10.1038/sj.bmt.1701240. Bone Marrow Transplant. 1998. PMID: 9645582

9

Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey.

Arslan O, Gürman G, Dilek I, Ozcan M, Koç H, Ilhan O, Akan H, Konuk N, Uysal A, Beksaç M. Arslan O, et al. Among authors: koc h. Haematologia (Budap). 1998;29(1):59-62. Haematologia (Budap). 1998. PMID: 9704259

10

Serum erythropoietin levels in patients with leukemia on cytostatic treatment.

Aydogdu I, Ilhan O, Beksac M, Koc H, Akan H, Konuk N, Uysal A. Aydogdu I, et al. Among authors: koc h. Haematologia (Budap). 1998;29(2):133-7. Haematologia (Budap). 1998. PMID: 9728805 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters